Dynavax Announces Collaboration with the University of Queensland and the Coalition for Epidemic Preparedness (CEPI) Focused on the Development of a Coronavirus (COVID-19) Vaccine
Dynavax is providing CpG 1018, the adjuvant contained in HEPLISAV-B, to support the rapid development of a COVID-19 vaccine EMERYVILLE, Calif., March 02, 2020 (GLOBE NEWSWIRE) — Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on…